Theodore K. Malmstrom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Theodore K. Malmstrom has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Douglas K. Miller
Regenstrief Institute, Inc. and Center for Aging Research Indiana University School of Medicine Indianapolis IN 46202 USA
7 shared publications- Fredric D. Wolinsky
Division of General Internal Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
7 shared publications - Mario Schootman
University of Arkansas for Medical Sciences 2708 South 48th Street
5 shared publications - Douglas K. Miller
Regenstrief Institute, Indiana University Center for Aging Research, Indianapolis, Indiana; School of Medicine, Indiana University, Indianapolis, Indiana
4 shared publications Elena M. Andresen
Department of Epidemiology and Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, Florida
4 shared publications- J. Philip Miller
Institute for Informatics, Data Science, and Biostatistics (I2DB), Washington University in St. Louis School of Medicine, St. Louis, MO, United States
4 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 7 July 2015
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 7 (1) , 28-36
SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes
Background A brief, inexpensive screening test for sarcopenia would be helpful for clinicians and their patients. To screen for persons with sarcopenia, we developed a simple five‐item questionnaire (SARC‐F) based on cardinal features or consequences of sarcopenia. Methods We investigated the utility of SARC‐F in the African American Health (AAH) study, Baltimore Longitudinal Study of Aging (BLSA), and National Health and Nutrition Examination Survey (NHANES). Internal consistency reliability for SARC‐F was determined using Cronbach's alpha. We evaluated SARC‐F factorial validity using principal components analysis and criterion validity by examining its association with exam‐based indicators of sarcopenia. Construct validity was examined using cross‐sectional and longitudinal differences among those with high (≥4) vs. low (<4) SARC‐F scores for mortality and health outcomes. Results SARC‐F exhibited good internal consistency reliability and factorial, criterion, and construct validity. AAH participants with SARC‐F scores ≥ 4 had more Instrumental Activity of Daily Living (IADL) deficits, slower chair stand times, lower grip strength, lower short physical performance battery scores, and a higher likelihood of recent hospitalization and of having a gait speed of <0.8 m/s. SARC‐F scores ≥ 4 in AAH also were associated with 6 year IADL deficits, slower chair stand times, lower short physical performance battery scores, having a gait speed of <0.8 m/s, being hospitalized recently, and mortality. SARC‐F scores ≥ 4 in the BLSA cohort were associated with having more IADL deficits and lower grip strength (both hands) in cross‐sectional comparisons and with IADL deficits, lower grip strength (both hands), and mortality at follow‐up. NHANES participants with SARC‐F scores ≥ 4 had slower 20 ft walk times, had lower peak force knee extensor strength, and were more likely to have been hospitalized recently in cross‐sectional analyses. Conclusions The SARC‐F proved internally consistent and valid for detecting persons at risk for adverse outcomes from sarcopenia in AAH, BLSA, and NHANES.
- 7 July 2015
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 7 (1) , 28-36
Top Cited PapersOpen AccessSARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes
Background A brief, inexpensive screening test for sarcopenia would be helpful for clinicians and their patients. To screen for persons with sarcopenia, we developed a simple five‐item questionnaire (SARC‐F) based on cardinal features or consequences of sarcopenia. Methods We investigated the utility of SARC‐F in the African American Health (AAH) study, Baltimore Longitudinal Study of Aging (BLSA), and National Health and Nutrition Examination Survey (NHANES). Internal consistency reliability for SARC‐F was determined using Cronbach's alpha. We evaluated SARC‐F factorial validity using principal components analysis and criterion validity by examining its association with exam‐based indicators of sarcopenia. Construct validity was examined using cross‐sectional and longitudinal differences among those with high (≥4) vs. low (<4) SARC‐F scores for mortality and health outcomes. Results SARC‐F exhibited good internal consistency reliability and factorial, criterion, and construct validity. AAH participants with SARC‐F scores ≥ 4 had more Instrumental Activity of Daily Living (IADL) deficits, slower chair stand times, lower grip strength, lower short physical performance battery scores, and a higher likelihood of recent hospitalization and of having a gait speed of <0.8 m/s. SARC‐F scores ≥ 4 in AAH also were associated with 6 year IADL deficits, slower chair stand times, lower short physical performance battery scores, having a gait speed of <0.8 m/s, being hospitalized recently, and mortality. SARC‐F scores ≥ 4 in the BLSA cohort were associated with having more IADL deficits and lower grip strength (both hands) in cross‐sectional comparisons and with IADL deficits, lower grip strength (both hands), and mortality at follow‐up. NHANES participants with SARC‐F scores ≥ 4 had slower 20 ft walk times, had lower peak force knee extensor strength, and were more likely to have been hospitalized recently in cross‐sectional analyses. Conclusions The SARC‐F proved internally consistent and valid for detecting persons at risk for adverse outcomes from sarcopenia in AAH, BLSA, and NHANES.
- Open Access
- 7 July 2015
- Published by Elsevier in The Journal of nutrition, health and aging
- Vol. 19 (7) , 741-744
The Rapid Cognitive Screen (RCS): A point-of-care screening for dementia and mild cognitive impairment
- 7 July 2015
- Published by Elsevier in The Journal of nutrition, health and aging
- Vol. 19 (7) , 741-744
Open AccessThe Rapid Cognitive Screen (RCS): A point-of-care screening for dementia and mild cognitive impairment
- Top Cited Papers
- 17 March 2014
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 62 (4) , 721-726
A Comparison of Four Frailty Models
Objectives: To determine how well the interview‐based, clinic‐friendly International Academy of Nutrition and Aging ( FRAIL ) frailty scale predicts future disability and mortality in the African American Health ( AAH ) cohort compared with the clinic‐friendly Study of Osteoporotic Fractures ( SOF ) frailty scale, the phenotype‐based Cardiovascular Health Study ( CHS ) frailty scale, and the comprehensive Frailty Index ( FI ). Design: Longitudinal cohort study. Setting: Metropolitan St. Louis, Missouri. Participants: African American Health is a population‐based panel study of African Americans (baseline age 49–65) from St. Louis, Missouri. Participants completed in‐home assessments at baseline (N = 998) and 3‐ (n = 853) and 9‐ (n = 582) year follow‐up. Measurements: Outcomes included activity of daily living ( ADL ) and instrumental ADL difficulties at 3 and 9 years and 9‐year mortality. Frailty measures included the FRAIL , SOF , and CHS scales and the FI . Results: The FRAIL , SOF , CHS , and FI measures predicted new 3‐ and 9‐year disability, and the FRAIL and FI scales predicted 9‐year mortality. Receiver operating characteristic ( ROC ) contrasts showed that the FRAIL scale performed as well as (9‐year disability and mortality) or better than (3‐year disability) the CHS and SOF scales and the FI better than the FRAIL , CHS , and SOF scales for all outcomes except the FRAIL and CHS scales for 9‐year ADL difficulties. The CHS and SOF scales were equivalent for all outcomes in ROC contrasts. Conclusion: Overall the FI and the FRAIL scale exhibited the strongest predictive validity for disability and mortality in AAH . The best prediction tool to identify frail individuals at risk of disability and mortality may be one that includes a comorbidity measure. The FRAIL scale includes a comorbidity item and is a brief interview‐based measure that is easy to administer, score, and interpret. The FRAIL scale has demonstrated validity and may prove to be a valuable scale for use by clinicians.
- 17 March 2014
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 62 (4) , 721-726
Top Cited PapersA Comparison of Four Frailty Models
Objectives: To determine how well the interview‐based, clinic‐friendly International Academy of Nutrition and Aging ( FRAIL ) frailty scale predicts future disability and mortality in the African American Health ( AAH ) cohort compared with the clinic‐friendly Study of Osteoporotic Fractures ( SOF ) frailty scale, the phenotype‐based Cardiovascular Health Study ( CHS ) frailty scale, and the comprehensive Frailty Index ( FI ). Design: Longitudinal cohort study. Setting: Metropolitan St. Louis, Missouri. Participants: African American Health is a population‐based panel study of African Americans (baseline age 49–65) from St. Louis, Missouri. Participants completed in‐home assessments at baseline (N = 998) and 3‐ (n = 853) and 9‐ (n = 582) year follow‐up. Measurements: Outcomes included activity of daily living ( ADL ) and instrumental ADL difficulties at 3 and 9 years and 9‐year mortality. Frailty measures included the FRAIL , SOF , and CHS scales and the FI . Results: The FRAIL , SOF , CHS , and FI measures predicted new 3‐ and 9‐year disability, and the FRAIL and FI scales predicted 9‐year mortality. Receiver operating characteristic ( ROC ) contrasts showed that the FRAIL scale performed as well as (9‐year disability and mortality) or better than (3‐year disability) the CHS and SOF scales and the FI better than the FRAIL , CHS , and SOF scales for all outcomes except the FRAIL and CHS scales for 9‐year ADL difficulties. The CHS and SOF scales were equivalent for all outcomes in ROC contrasts. Conclusion: Overall the FI and the FRAIL scale exhibited the strongest predictive validity for disability and mortality in AAH . The best prediction tool to identify frail individuals at risk of disability and mortality may be one that includes a comorbidity measure. The FRAIL scale includes a comorbidity item and is a brief interview‐based measure that is easy to administer, score, and interpret. The FRAIL scale has demonstrated validity and may prove to be a valuable scale for use by clinicians.
- Open Access
- 29 October 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 1024
Observer ratings of neighborhoods: comparison of two methods
Although neighborhood characteristics have important relationships with health outcomes, direct observation involves imperfect measurement. The African American Health (AAH) study included two observer neighborhood rating systems (5-item Krause and 18-item AAH Neighborhood Assessment Scale [NAS]), initially fielded at two different waves. Good measurement characteristics were previously shown for both, but there was more rater variability than desired. In 2010 both measures were re-fielded together, with enhanced training and field methods implemented to decrease rater variability while maintaining psychometric properties.
- 29 October 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 1024
Open AccessObserver ratings of neighborhoods: comparison of two methods
Although neighborhood characteristics have important relationships with health outcomes, direct observation involves imperfect measurement. The African American Health (AAH) study included two observer neighborhood rating systems (5-item Krause and 18-item AAH Neighborhood Assessment Scale [NAS]), initially fielded at two different waves. Good measurement characteristics were previously shown for both, but there was more rater variability than desired. In 2010 both measures were re-fielded together, with enhanced training and field methods implemented to decrease rater variability while maintaining psychometric properties.
- Open Access
- 8 September 2013
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 13 (1) , 66
The St. Louis African American health-heart study: methodology for the study of cardiovascular disease and depression in young-old African Americans
Background: Coronary artery disease (CAD) is a major cause of death and disability worldwide. Depression has complex bidirectional adverse associations with CAD, although the mechanisms mediating these relationships remain unclear. Compared to European Americans, African Americans (AAs) have higher rates of morbidity and mortality from CAD. Although depression is common in AAs, its role in the development and features of CAD in this group has not been well examined. This project hypothesizes that the relationships between depression and CAD can be explained by common physiological pathways and gene-environment interactions. Thus, the primary aims of this ongoing project are to: a) determine the prevalence of CAD and depression phenotypes in a population-based sample of community-dwelling older AAs; b) examine the relationships between CAD and depression phenotypes in this population; and c) evaluate genetic variants from serotoninP and inflammatory pathways to discover potential gene-depression interactions that contribute significantly to the presence of CAD in AAs. Methods/design: The St. Louis African American Health (AAH) cohort is a population-based panel study of community-dwelling AAs born in 1936–1950 (inclusive) who have been followed from 2000/2001 through 2010. The AAH-Heart study group is a subset of AAH participants recruited in 2009–11 to examine the inter-relationships between depression and CAD in this population. State-of-the-art CAD phenotyping is based on cardiovascular characterizations (coronary artery calcium, carotid intima-media thickness, cardiac structure and function, and autonomic function). Depression phenotyping is based on standardized questionnaires and detailed interviews. Single nucleotide polymorphisms of selected genes in inflammatory and serotonin-signaling pathways are being examined to provide information for investigating potential gene-depression interactions as modifiers of CAD traits. Information from the parent AAH study is being used to provide population-based prevalence estimates. Inflammatory and other biomarkers provide information about potential pathways. Discussion: This population-based investigation will provide valuable information on the prevalence of both depression and CAD phenotypes in this population. The study will examine interactions between depression and genetic variants as modulators of CAD, with the intent of detecting mechanistic pathways linking these diseases to identify potential therapeutic targets. Analytic results will be reported as they become available.
- 8 September 2013
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 13 (1) , 66
Open AccessThe St. Louis African American health-heart study: methodology for the study of cardiovascular disease and depression in young-old African Americans
Background: Coronary artery disease (CAD) is a major cause of death and disability worldwide. Depression has complex bidirectional adverse associations with CAD, although the mechanisms mediating these relationships remain unclear. Compared to European Americans, African Americans (AAs) have higher rates of morbidity and mortality from CAD. Although depression is common in AAs, its role in the development and features of CAD in this group has not been well examined. This project hypothesizes that the relationships between depression and CAD can be explained by common physiological pathways and gene-environment interactions. Thus, the primary aims of this ongoing project are to: a) determine the prevalence of CAD and depression phenotypes in a population-based sample of community-dwelling older AAs; b) examine the relationships between CAD and depression phenotypes in this population; and c) evaluate genetic variants from serotoninP and inflammatory pathways to discover potential gene-depression interactions that contribute significantly to the presence of CAD in AAs. Methods/design: The St. Louis African American Health (AAH) cohort is a population-based panel study of community-dwelling AAs born in 1936–1950 (inclusive) who have been followed from 2000/2001 through 2010. The AAH-Heart study group is a subset of AAH participants recruited in 2009–11 to examine the inter-relationships between depression and CAD in this population. State-of-the-art CAD phenotyping is based on cardiovascular characterizations (coronary artery calcium, carotid intima-media thickness, cardiac structure and function, and autonomic function). Depression phenotyping is based on standardized questionnaires and detailed interviews. Single nucleotide polymorphisms of selected genes in inflammatory and serotonin-signaling pathways are being examined to provide information for investigating potential gene-depression interactions as modifiers of CAD traits. Information from the parent AAH study is being used to provide population-based prevalence estimates. Inflammatory and other biomarkers provide information about potential pathways. Discussion: This population-based investigation will provide valuable information on the prevalence of both depression and CAD phenotypes in this population. The study will examine interactions between depression and genetic variants as modulators of CAD, with the intent of detecting mechanistic pathways linking these diseases to identify potential therapeutic targets. Analytic results will be reported as they become available.
- Open Access
- 27 March 2013
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 4 (3) , 179-186
Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle‐aged African Americans
Background: Recent efforts to provide a consensus definition propose that sarcopenia be considered a clinical syndrome associated with the loss of both skeletal muscle mass and muscle function that occurs with aging. Validation of sarcopenia definitions that include both low muscle mass and poor muscle function is needed.Methods: In the population‐based African American Health (AAH) study (N = 998 at baseline/wave 1), muscle mass and mobility were evaluated in a clinical testing center in a subsample of N = 319 persons (ages 52–68) at wave 4 (2004). Muscle mass was measured using dual energy x‐ray absorptiometry and mobility by a 6‐min walk test and 4‐m gait walk test. Height corrected appendicular skeletal mass (ASM; 9.0 ± 1.5 in n = 124 males, 8.3 ± 2.2 in n = 195 females) was computed as total lean muscle mass in arms and legs (kilograms) divided by the square of height (meters). Cross‐sectional and longitudinal (6‐year) associations of low ASM (bottom 25 % AAH sample; p = .008) and frailty (p = .040) but not with ADL difficulties or falls in cross‐sectional analyses; and with ADL difficulties (p = .022), IADL difficulties (p = .006), frailty (p = .039), and mortality (p = .003) but not with falls in longitudinal analyses adjusted for age and gender. Low ASM alone was marginally associated with mortality (p = .085) but not with other outcomes in cross‐sectional or longitudinal analyses.Conclusion: Low ASM with limited mobility is associated with poor health outcomes among late middle‐aged African Americans.
- 27 March 2013
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 4 (3) , 179-186
Open AccessLow appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle‐aged African Americans
Background: Recent efforts to provide a consensus definition propose that sarcopenia be considered a clinical syndrome associated with the loss of both skeletal muscle mass and muscle function that occurs with aging. Validation of sarcopenia definitions that include both low muscle mass and poor muscle function is needed.Methods: In the population‐based African American Health (AAH) study (N = 998 at baseline/wave 1), muscle mass and mobility were evaluated in a clinical testing center in a subsample of N = 319 persons (ages 52–68) at wave 4 (2004). Muscle mass was measured using dual energy x‐ray absorptiometry and mobility by a 6‐min walk test and 4‐m gait walk test. Height corrected appendicular skeletal mass (ASM; 9.0 ± 1.5 in n = 124 males, 8.3 ± 2.2 in n = 195 females) was computed as total lean muscle mass in arms and legs (kilograms) divided by the square of height (meters). Cross‐sectional and longitudinal (6‐year) associations of low ASM (bottom 25 % AAH sample; p = .008) and frailty (p = .040) but not with ADL difficulties or falls in cross‐sectional analyses; and with ADL difficulties (p = .022), IADL difficulties (p = .006), frailty (p = .039), and mortality (p = .003) but not with falls in longitudinal analyses adjusted for age and gender. Low ASM alone was marginally associated with mortality (p = .085) but not with other outcomes in cross‐sectional or longitudinal analyses.Conclusion: Low ASM with limited mobility is associated with poor health outcomes among late middle‐aged African Americans.
- Open Access
- 27 September 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 827
Childhood school segregation and later life sense of control and physical performance in the African American Health cohort
The association between childhood school desegregation and later life sense of control and physical performance among African Americans is not clear. We hypothesized that childhood school desegregation adversely affected the sense of control of in later life, and that this reduced sense of control accounts in part for reduced physical performance.
- 27 September 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 827
Open AccessChildhood school segregation and later life sense of control and physical performance in the African American Health cohort
The association between childhood school desegregation and later life sense of control and physical performance among African Americans is not clear. We hypothesized that childhood school desegregation adversely affected the sense of control of in later life, and that this reduced sense of control accounts in part for reduced physical performance.
- 9 September 2010
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 58 (10) , 1941-1945
Urinary and Fecal Incontinence and Quality of Life in African Americans
OBJECTIVES: To investigate associations between quality of life (QoL) and incontinence in a population‐based African‐American sample. DESIGN: Cross‐sectional survey. SETTING: Metropolitan St. Louis, Missouri. PARTICIPANTS: Eight hundred fifty‐three non‐institutionalized African Americans aged 52 to 68 in the African American Health study. MEASUREMENTS: Respondents who reported having involuntarily lost urine over the previous month were classified as having urinary incontinence (UI), and respondents who reported having lost control of their bowels or stool over the past year were classified as having fecal incontinence (FI). QoL was measured using the Medical Outcomes Study 36‐Item Short‐Form Health Survey (SF‐36) and the 11‐item Center for Epidemiologic Studies Depression Scale (CES‐D). RESULTS: Prevalences of UI and FI were 12.1% (weighted n=102/841) and 5.0% (weighted n=42/841). Participants with UI and those with FI had worse SF‐36 scores than their referent groups (physical function −15.5 and −38.1 points, respectively; role physical −13.2 and −26.5 points; bodily pain −15.7 and −24.5 points; general health perceptions −15.5 and −27.6 points; vitality −15.0 and −16.5 points; social functioning −18.4 and −25.6 points; role emotional −13.2 and −22.1 points; mental health −12.2 and −17.5 points; all Ps <.001), adjusting for age, sex, body mass index, and chronic conditions. Proportions with clinically relevant levels of depressive symptoms were also higher in both groups (UI+17.9%; P <.001) and FI (+37.2%; P <.001) than in their referent groups. CONCLUSION: UI and FI were strongly associated with worse health‐related QoL as well as symptoms of depression in this population‐based sample of African Americans.
- 9 September 2010
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 58 (10) , 1941-1945
Urinary and Fecal Incontinence and Quality of Life in African Americans
OBJECTIVES: To investigate associations between quality of life (QoL) and incontinence in a population‐based African‐American sample. DESIGN: Cross‐sectional survey. SETTING: Metropolitan St. Louis, Missouri. PARTICIPANTS: Eight hundred fifty‐three non‐institutionalized African Americans aged 52 to 68 in the African American Health study. MEASUREMENTS: Respondents who reported having involuntarily lost urine over the previous month were classified as having urinary incontinence (UI), and respondents who reported having lost control of their bowels or stool over the past year were classified as having fecal incontinence (FI). QoL was measured using the Medical Outcomes Study 36‐Item Short‐Form Health Survey (SF‐36) and the 11‐item Center for Epidemiologic Studies Depression Scale (CES‐D). RESULTS: Prevalences of UI and FI were 12.1% (weighted n=102/841) and 5.0% (weighted n=42/841). Participants with UI and those with FI had worse SF‐36 scores than their referent groups (physical function −15.5 and −38.1 points, respectively; role physical −13.2 and −26.5 points; bodily pain −15.7 and −24.5 points; general health perceptions −15.5 and −27.6 points; vitality −15.0 and −16.5 points; social functioning −18.4 and −25.6 points; role emotional −13.2 and −22.1 points; mental health −12.2 and −17.5 points; all Ps <.001), adjusting for age, sex, body mass index, and chronic conditions. Proportions with clinically relevant levels of depressive symptoms were also higher in both groups (UI+17.9%; P <.001) and FI (+37.2%; P <.001) than in their referent groups. CONCLUSION: UI and FI were strongly associated with worse health‐related QoL as well as symptoms of depression in this population‐based sample of African Americans.
- 1 April 2009
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 23 (2) , 117-123
Informant-based Dementia Screening in a Population-based Sample of African Americans
Background An informant-based screening tool for dementia may be useful in population-based studies of minority populations. Objective Investigate the feasibility of screening for very mild dementia in a community sample of African Americans using an informant-based screening tool (AD8). Design Cohort study. Participants One hundred forty-seven persons from the African American Health (AAH) project were screened for dementia; 61 of 93 who were invited had follow-up clinical assessments for dementia diagnosis. Measurements The AD8, Mini-Mental State Examination, Short Blessed Test, Brief Instrument for Dementia Detection, and a neuropsychologic battery were administered at visit 1. The Clinical Dementia Rating (CDR) was administered at visit 2 by clinicians blinded to visit 1 results; the presence of dementia was determined by a CDR greater than 0. Results Four hundred sixty-five individuals from the AAH cohort were sent a letter describing the study and, among this group, 252 individuals were contacted by phone to request participation in this study. Six percent (14/252) of the participants contacted by phone were unable to identify an informant (required for the AD8). One hundred fifty individuals agreed by phone to participate of which 2% (n=3) did not have an informant available at the time of participation. The AD8 alone was effective at discriminating between CDR 0 and CDR 0.5 (area under the curve=0.847; P<0.001; 95% confidence interval, 0.73-0.96). Conclusions A brief informant-based instrument, the AD8, has high sensitivity and specificity for distinguishing CDR 0 from CDR 0.5 in the community. Informant availability may not be a barrier for using the AD8 in an African American community sample; however, further study in larger samples with a higher response rate, different community settings (eg, community clinics), and among older age groups (eg, age 75+) is warranted to confirm this.
- 1 April 2009
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 23 (2) , 117-123
Informant-based Dementia Screening in a Population-based Sample of African Americans
Background An informant-based screening tool for dementia may be useful in population-based studies of minority populations. Objective Investigate the feasibility of screening for very mild dementia in a community sample of African Americans using an informant-based screening tool (AD8). Design Cohort study. Participants One hundred forty-seven persons from the African American Health (AAH) project were screened for dementia; 61 of 93 who were invited had follow-up clinical assessments for dementia diagnosis. Measurements The AD8, Mini-Mental State Examination, Short Blessed Test, Brief Instrument for Dementia Detection, and a neuropsychologic battery were administered at visit 1. The Clinical Dementia Rating (CDR) was administered at visit 2 by clinicians blinded to visit 1 results; the presence of dementia was determined by a CDR greater than 0. Results Four hundred sixty-five individuals from the AAH cohort were sent a letter describing the study and, among this group, 252 individuals were contacted by phone to request participation in this study. Six percent (14/252) of the participants contacted by phone were unable to identify an informant (required for the AD8). One hundred fifty individuals agreed by phone to participate of which 2% (n=3) did not have an informant available at the time of participation. The AD8 alone was effective at discriminating between CDR 0 and CDR 0.5 (area under the curve=0.847; P<0.001; 95% confidence interval, 0.73-0.96). Conclusions A brief informant-based instrument, the AD8, has high sensitivity and specificity for distinguishing CDR 0 from CDR 0.5 in the community. Informant availability may not be a barrier for using the AD8 in an African American community sample; however, further study in larger samples with a higher response rate, different community settings (eg, community clinics), and among older age groups (eg, age 75+) is warranted to confirm this.
- Open Access
- 1 May 2008
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 63 (5) , 487-494
Adverse Outcomes and Correlates of Change in the Short Physical Performance Battery Over 36 Months in the African American Health Project
Background. The Short Physical Performance Battery (SPPB) is a well-established measure of lower body physical functioning in older persons but has not been adequately examined in African Americans or younger persons. Moreover, factors associated with changes in SPPB over time have not been reported. Methods. A representative sample of 998 African Americans (49–65 years old at baseline) living in St. Louis, Missouri were followed for 36 months to examine the predictive validity of SPPB in this population and identify factors associated with changes in SPPB. SPPB was calibrated to this population, ranged from 0 (worst) to 12 (best), and required imputation for about 50% of scores. Adverse outcomes of baseline SPPB included death, nursing home placement, hospitalization, physician visits, incident basic and instrumental activity of daily living disabilities, and functional limitations. Changes in SPPB over 36 months were modeled. Results. Adjusted for appropriate covariates, weighted appropriately, and using propensity scores to address potential selection bias, baseline SPPB scores were associated with all adverse outcomes except physician visits, and were marginally associated with hospitalization. Declines in SPPB scores were associated with low falls efficacy (b = −1.311), perceived income adequacy (−0.121), older age (−0.073 per year), poor vision (−0.754), diabetes mellitus (−0.565), refusal to report household income (1.48), ever had Medicaid insurance (−0.610), obesity (−0.437), hospitalization in the prior year (−0.521), and kidney disease (−.956). Conclusions. The effect of baseline SPPB on adverse outcomes in this late middle-age African American population confirms reports involving older, primarily white participants. Alleviating deterioration in lower body physical functioning guided by the associated covariates may avoid or delay multiple age-associated adverse outcomes.
- 1 May 2008
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 63 (5) , 487-494
Open AccessAdverse Outcomes and Correlates of Change in the Short Physical Performance Battery Over 36 Months in the African American Health Project
Background. The Short Physical Performance Battery (SPPB) is a well-established measure of lower body physical functioning in older persons but has not been adequately examined in African Americans or younger persons. Moreover, factors associated with changes in SPPB over time have not been reported. Methods. A representative sample of 998 African Americans (49–65 years old at baseline) living in St. Louis, Missouri were followed for 36 months to examine the predictive validity of SPPB in this population and identify factors associated with changes in SPPB. SPPB was calibrated to this population, ranged from 0 (worst) to 12 (best), and required imputation for about 50% of scores. Adverse outcomes of baseline SPPB included death, nursing home placement, hospitalization, physician visits, incident basic and instrumental activity of daily living disabilities, and functional limitations. Changes in SPPB over 36 months were modeled. Results. Adjusted for appropriate covariates, weighted appropriately, and using propensity scores to address potential selection bias, baseline SPPB scores were associated with all adverse outcomes except physician visits, and were marginally associated with hospitalization. Declines in SPPB scores were associated with low falls efficacy (b = −1.311), perceived income adequacy (−0.121), older age (−0.073 per year), poor vision (−0.754), diabetes mellitus (−0.565), refusal to report household income (1.48), ever had Medicaid insurance (−0.610), obesity (−0.437), hospitalization in the prior year (−0.521), and kidney disease (−.956). Conclusions. The effect of baseline SPPB on adverse outcomes in this late middle-age African American population confirms reports involving older, primarily white participants. Alleviating deterioration in lower body physical functioning guided by the associated covariates may avoid or delay multiple age-associated adverse outcomes.